Chen Man, Feng Mengya, Lei Hai, Ren Shengnan, Yang Dechun
Department of Breast Surgery, Caner Hospital of Yunnan Province, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Department of Breast Surgery, The People's Hospital of Chuxiong Yi Autonomous Prefecture, No. 318 Lucheng South Road, Chuxiong, Yunnan, China.
Cancer Cell Int. 2024 Oct 26;24(1):349. doi: 10.1186/s12935-024-03531-x.
Breast cancer is currently the most frequent malignant tumor and the leading cause of cancer death among women globally. Although the five-year survival rate for early breast cancer has risen to more than 90%, medication resistance persists in advanced breast cancer and some intractable breast cancer, resulting in a poor prognosis, a high recurrence rate, and a low survival rate. Single-cell sequencing (SCS) is the study of a single cell's gene structure and expression level differences in order to discover unusual molecular subgroups, disease development, and a variety of mechanisms. This review briefly discusses single-cell sequencing and its application, and lists the research on single-cell sequencing in the development and metastasis of breast cancer, in order to bring fresh ideas for the comprehensive treatment of breast cancer.
乳腺癌是目前全球女性中最常见的恶性肿瘤,也是癌症死亡的主要原因。尽管早期乳腺癌的五年生存率已升至90%以上,但晚期乳腺癌和一些难治性乳腺癌仍存在耐药性,导致预后不良、复发率高和生存率低。单细胞测序(SCS)是对单个细胞的基因结构和表达水平差异进行研究,以发现异常分子亚群、疾病发展及多种机制。本文简要讨论单细胞测序及其应用,并列举单细胞测序在乳腺癌发生发展和转移方面的研究,以期为乳腺癌的综合治疗带来新思路。